Organon & Co (OGN)

NYSE HEALTHCARE
$13.34 -0.07% RSI 75 Overbought Add Alert

Moving Averages

SMA 200
$8.57
Price above

Company Profile

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - GENERAL
Market Cap
$3.50B
P/E Ratio
14.31
EPS
$0.93
Beta
1.546
Dividend Yield
0.60%
52-Week High
$13.42
52-Week Low
$5.68

Similar stocks in DRUG MANUFACTURERS - GENERAL

Data last updated: May 14, 2026 at 2:03 AM EDT

Track OGN for free

Get e-mail RSI alerts when Organon & Co enters oversold or overbought territory. Free forever.

Add Alert